韩国全国性研究:肺康复与慢阻肺患者急性加重及死亡率降低相关
该研究基于韩国健康保险审查评估服务数据库(2015-2019年),分析慢阻肺患者肺康复实施率、医疗费用及临床结局。结果显示仅1.43%患者接受肺康复,但年实施率从0.03%升至1.4%,且肺康复与急性加重率和死亡率降低相关。
要点
- 韩国慢阻肺患者肺康复实施率仅1.43%,但医保覆盖后逐年上升。
- 肺康复组中重度及重度急性加重发生率和频率均低于康复前。
- 肺康复与首次急性加重时间延长及死亡率显著降低相关。
核心结论
- 医保覆盖提高肺康复实施率,且肺康复改善慢阻肺患者结局包括减少急性加重和死亡率。
研究设计与样本
- 基于韩国健康保险审查评估服务数据库(2015-2019年)的全国性研究,分析慢阻肺患者肺康复实施率、直接医疗费用及临床结局。
主要发现
- 全部韩国慢阻肺患者中仅1.43%接受肺康复,年实施率从0.03%逐渐升至1.4%。
- 肺康复组直接医疗费用显著高于非肺康复组,但两组费用趋势分别呈下降和上升。
- 肺康复后中重度及重度急性加重发生率和频率均低于肺康复前。
- 肺康复组首次中重度及重度急性加重时间均长于非肺康复组。
- 肺康复实施与死亡率显著降低相关。
临床怎么用
- 应积极推动慢阻肺患者参与肺康复,尤其通过医保覆盖提高实施率。
- 肺康复可作为减少慢阻肺急性加重和死亡风险的干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor uptake to pulmonary rehabilitation (PR) is still challenging around the world. There have been few nationwide studies investigating whether PR impacts patient outcomes in COPD. We investigated the change of annual PR implementation rate, medical costs, and COPD outcomes including exacerbation rates and mortality between 2015 and 2019. RESEARCH QUESTION: Does PR implementation improve outcomes in patients with COPD in terms of direct cost, exacerbation, and mortality? STUDY DESIGN AND METHODS: Data of patients with COPD extracted from a large Korean Health Insurance Review and Assessment service database (2015-2019) were analyzed to determine the trends of annual PR implementation rate and direct medical costs of PR. Comparison of COPD exacerbation rates between pre-PR and post-PR, and the time to first exacerbation and mortality rate according to PR implementation, were also assessed. RESULTS: Among all patients with COPD in South Korea, only 1.43% received PR. However, the annual PR implementation rate gradually increased from 0.03% to 1.4% during 4 years, especially after health insurance coverage commencement. The direct medical cost was significantly higher in the PR group than the non-PR group, but the costs in these groups showed decreasing and increasing trends, respectively. Both the incidence rate and frequency of moderate-to-severe and severe exacerbations were lower during the post-PR period compared with the pre-PR period. The time to the first moderate-to-severe and severe exacerbations was longer in the PR group than the non-PR group. Finally, PR implementation was associated with a significant decrease in mortality. INTERPRETATION: We concluded that health insurance coverage increases PR implementation rates. Moreover, PR contributes toward improving outcomes including reducing exacerbation and mortality in patients with COPD. However, despite the well-established benefits of PR, its implementation rate remains suboptimal.
引用
- Choi, Kim, Kim, et al. Pulmonary Rehabilitation Is Associated With Decreased Exacerbation and Mortality in Patients With COPD: A Nationwide Korean Study. Chest. 2023. PMID: 37806492. doi:10.1016/j.chest.2023.09.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。